These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7325769)

  • 1. Bioequivalence of two dipyridamole preparations and inhibitory effect on the platelet adenosine uptake in man.
    Chevolet C; Van de Velde V; Weisenberger H; Herman A; Dresse A
    Arch Int Pharmacodyn Ther; 1981 Oct; 253(2):321-2. PubMed ID: 7325769
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of oral dipyridamole (Persantine) and its effect on platelet adenosine uptake in man.
    Dresse A; Chevolet C; Delapierre D; Masset H; Weisenberger H; Bozler G; Heinzel G
    Eur J Clin Pharmacol; 1982; 23(3):229-34. PubMed ID: 6756935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity.
    Gresele P; Arnout J; Deckmyn H; Vermylen J
    Thromb Haemost; 1986 Feb; 55(1):12-8. PubMed ID: 3704998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of dipyridamole to human platelets and to alpha1 acid glycoprotein and its significance for the inhibition of adenosine uptake.
    Subbarao K; Rucinski B; Rausch MA; Schmid K; Niewiarowski S
    J Clin Invest; 1977 Oct; 60(4):936-43. PubMed ID: 893681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dipyridamole and its monoglucuronide derivative on adenosine uptake by human platelets and ADP-induced platelet aggregation.
    Subbarao K; Rucinski B; Niewiarowski S
    Biochem Pharmacol; 1977 May; 26(9):906-7. PubMed ID: 861060
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiating effect of adenosine on other inhibitors of platelet aggregation.
    Murakami M; Odake K; Takase M; Yoshino K
    Thromb Diath Haemorrh; 1972 Apr; 27(2):252-62. PubMed ID: 5049615
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of dipyridamol on the electrokinetic potential of platelets.
    Aznar J; Vallés J
    Rev Esp Fisiol; 1974 Jun; 30(2):77-9. PubMed ID: 4278529
    [No Abstract]   [Full Text] [Related]  

  • 8. Potentiation of the inhibitory effect of adenosine on platelet aggregation by drugs that prevent its uptake.
    Born GV; Mills DC
    J Physiol; 1969 May; 202(1):41P-42P. PubMed ID: 5770909
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation.
    Serebruany V; Sabaeva E; Booze C; Atar OD; Eisert C; Hanley D;
    Thromb Haemost; 2009 Sep; 102(3):538-43. PubMed ID: 19718475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bioequivalence study of two dipyridamole products.
    Arafat T; Saket M; Awad R; Ibrahim H; Saleh M; Gharaibeh M; Sallam E; Shuber M
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):564-7. PubMed ID: 2613391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL; Malinin AI; Sane DC
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of adenosine phosphorylation in platelets by dipyridamole.
    Rozenberg MC; Ledwidge CM; Wilcken DE; McKeon M
    J Lab Clin Med; 1971 Jan; 77(1):88-96. PubMed ID: 5540431
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of dipyridamole and RA 233 on human platelet function in vitro.
    Rifkin PL; Zucker MB
    Thromb Diath Haemorrh; 1973 Jun; 29(3):694-700. PubMed ID: 4761835
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of dipyridamole on adenosine uptake by platelets ex vivo.
    Summers A; Subbaraok ; Rucinski B; Niewiarowski S
    Thromb Res; 1977 Nov; 11(5):611-8. PubMed ID: 929510
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of intravenous adenosine diphosphate on the number of circulating platelets in experimental animals: inhibition by prostaglandin E1, dipyridamole, SH-869 and VK-774.
    Holmes IB; Smith GM; Freuler F
    Thromb Haemost; 1977 Feb; 37(1):36-46. PubMed ID: 402707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of acetylsalicylic acid. Dipyridamole and K 3920 on the secretion of platelet factor 4.
    Akman N
    Haematologica; 1980 Aug; 65(4):546-51. PubMed ID: 6774930
    [No Abstract]   [Full Text] [Related]  

  • 17. Preservation of platelets and blood products by intravenously administered dipyridamole in patients who undergo coronary artery bypass grafting.
    Reilly PA; Thompson M; Bayer A; Kazim F; Rosenfeld J; Glynn MF
    Can J Surg; 1987 Jul; 30(4):260-4. PubMed ID: 3496948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of aspirin and dipyridamole on platelet functions in Macaca fascicularis].
    Wang ZG; Po HG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Aug; 5(4):240-5. PubMed ID: 6228318
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of antiadhesive drugs on platelet function and metabolism.
    Ulutin SB; Yaramanci TE; Ulutin ON
    Acta Univ Carol Med Monogr; 1972; 53():237-46. PubMed ID: 4670732
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of dipyridamole and prostacyclin on rabbit platelet adherence in vitro and in vivo.
    Groves HM; Kinlough-Rathbone RL; Cazenave JP; Dejana E; Richardson M; Mustard JF
    J Lab Clin Med; 1982 Apr; 99(4):548-58. PubMed ID: 7038012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.